@Article{Kamel2025,
journal="Gastroenterology Review/Przegląd Gastroenterologiczny",
issn="1895-5770",
volume="20",
number="4",
year="2025",
title="One-year single-center follow-up study of ustekinumab and vedolizumab use in inflammatory bowel disease Egyptian patients as second-line therapy after anti-TNF failure",
author="Kamel, Shimaa
and Alaty, Waleed Hamed Abd
and Rashad, Heba
and Fathy, Dina
and Abdel-Samiee, Mohamed
and Hindy, Ibrahim
and Shaban, Ahmed
and Askar, Safaa",
pages="430--438",
doi="10.5114/pg.2025.156473",
url="http://dx.doi.org/10.5114/pg.2025.156473"
}